ArticleJournal of health, population, and nutrition2026
Association of emerging anthropometric ratios with arterial stiffness risk measured by pulse wave velocity: insights from a middle-eastern population.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correlation analysis between eight anthropometric indicators and arterial stiffness in relatively healthy Chinese adults.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundArterial stiffness (AS), a strong risk factor for atherosclerosis and coronary artery disease (CAD), is typically assessed using pulse wave velocity (PWV). This study takes a unique approach by exploring the relationship between novel anthropometric indices and AS in a large cohort study.
methodThis cross-sectional study was conducted during Phase II of the Mashhad Stroke and Heart Atherosclerotic Disorders (MASHAD) study, a 10-year cohort (2010-2020). Out of the original 9704 participants at the beginning of the MASHAD cohort study, 310 healthy participants, 206 individuals without confirmed cardiovascular disease (CVD), and 307 individuals with confirmed major cardiovascular events were randomly selected. PWV test was conducted using a specialized SphygmoCor XCEL System, and participants were grouped into two CVD and two non-CVD groups based on the median PWV < 6.9 or ≥ 6.9.
resultA total of 823 individuals took part in the study. The CVD group with PWV ≥ 6.9 m/s had the highest mean age of 51.37 ± 7.07 years. Multinomial logistic regression analysis revealed that with each unit increase in weight-adjusted waist index (WWI) and visceral adiposity index (VAI), the odds of AS increased by 25.7% [OR: 1.257 (1.002-1.576)] and 13.9% [OR: 1.139 (1.022-1.271)] (P-value = 0.048 and 0.019, respectively). Additionally, as lipid accumulation product (LAP) increased, the AS decreased by 0.4% [OR: 0.996 (0.993-0.999)] (P-value = 0.01). Moreover, height and arm-to-height ratio (AHR) resulted in a 3.7% [OR: 1.037 (1.003-1.073)] and 6.4% [OR: 1.064 (1.002-1.131)] increase in PWV risk (P-value = 0.034 and 0.044). In the CVD-, PWV ≥ 6.9 group, VAI posed a 16.4% [OR: 1.164 (1.051-1.289)] (P-value = 0.004) increase in AS with a one-unit increment.
conclusionWWI and VAI showed significant associations with AS in CVD patients. VAI was also linked to AS in non-CVD patients, with a stronger association than height and AHR. This contributes significantly to our understanding of vascular health. Equally noteworthy is the protective association of LAP against AS in non-CVD individuals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.